|
Forecast
Period
|
2026-2030
|
|
Market
Size (2024)
|
USD
103.50 Million
|
|
Market
Size (2030)
|
USD
138.82 Million
|
|
CAGR
(2025-2030)
|
5.12%
|
|
Fastest
Growing Segment
|
Hospitals
& Clinics
|
|
Largest
Market
|
South India
|
Market Overview
India Ventilator Market was valued at USD 103.50 Million in 2024 and is projected to reach USD 138.82 Million by 2030, growing at a CAGR of 5.12% during the forecast period.
A ventilator, also known as a mechanical ventilator, is a machine
that supports breathing by delivering oxygen into the lungs and removing carbon
dioxide from the body. It plays a crucial role in medical settings, especially when a patient's respiratory function is compromised, as in
severe cases of pneumonia or other respiratory diseases. Ventilators deliver a controlled amount of oxygen to the patient's lungs via a breathing tube or mask. The machine
assists the patient's breathing, ensuring that they receive sufficient oxygen
and that carbon dioxide is effectively eliminated.
In some cases, ventilators
can also provide additional support by providing positive pressure to help
inflate the lungs and improve oxygen exchange. These life-saving machines are
equipped with advanced features and settings that can be tailored to each patient's specific needs. Ventilators are operated by trained healthcare
professionals who closely monitor the patient's respiratory status and adjust
the settings accordingly. Ventilators are indispensable medical devices that
play a vital role in supporting patients with compromised breathing. Their
ability to deliver controlled oxygen and remove carbon dioxide ensures that
patients receive the necessary respiratory support, ultimately aiding in their
recovery and overall well-being. The Ventilator Market is the global industry focused on the production and sale of ventilators, life-saving machines used in healthcare facilities. These machines aid
individuals who are unable to breathe naturally, often due to acute conditions
or severe respiratory illnesses.
Key Market Drivers
Rising Burden of Respiratory Diseases
India is confronting an escalating respiratory health crisis that is directly translating into sustained ventilator demand across hospitals, ICUs, and home care settings. According to the Lancet, India is home to approximately 55 million COPD patients and 33 million asthmatics as of 2023, collectively accounting for over 10% of the global burden of these two diseases alone. The World Health Organization further reported that COPD caused approximately 1.2 million deaths in India in 2022, underscoring the severity of unmanaged respiratory conditions in the country. Worsening air quality in urban and industrial corridors, driven by vehicular emissions, construction dust, and crop burning, is significantly aggravating these conditions.
Tier-1 cities such as Delhi, Mumbai, Kolkata, and Bengaluru consistently record dangerous Air Quality Index (AQI) levels, directly correlating with a spike in emergency respiratory admissions. In addition, seasonal diseases such as influenza and pneumonia create periodic demand surges for ventilatory support. As healthcare awareness improves among patients and caregivers, early hospital admissions for respiratory distress are rising, further accelerating utilization of mechanical ventilators across both public and private facilities.
Expanding Geriatric Population
India's rapidly aging demographic is emerging as one of the most powerful structural drivers for long-term ventilator demand. Population projections indicate that individuals aged 60 and above will reach approximately 316 million by 2030, representing a near doubling from current figures. Aging is inherently associated with declining pulmonary function, weakened immune responses, and higher susceptibility to chronic diseases such as COPD, pneumonia, interstitial lung disease, and congestive heart failure, all of which frequently necessitate mechanical ventilation during acute episodes. Statistically, around 35% of India's elderly population is expected to suffer from at least one chronic health condition requiring medical intervention.
The growing prevalence of comorbidities, particularly the combination of diabetes, cardiovascular disease, and respiratory ailments in older patients, significantly increases the likelihood of ICU admissions requiring ventilatory support. Furthermore, the formal elder care sector in India is expanding with new assisted living facilities, nursing homes, and geriatric care hospitals increasingly procuring dedicated home care and transport ventilators to cater to non-ICU populations. This demographic shift guarantees a structurally growing base demand for ventilators well into 2030 and beyond.
Government Healthcare Infrastructure Initiatives
The Indian government's robust policy investments in healthcare access and infrastructure are creating strong procurement demand for ventilators at public hospitals, district health centers, and community health hubs. The flagship Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) scheme, with an allocation exceeding INR 64,000 crore for hospital and clinic development, is directly driving the acquisition of critical care equipment, including ventilators, in tier-2 and tier-3 cities. The National Health Mission (NHM) and PM-ABHIM (Pradhan Mantri Ayushman Bharat Health Infrastructure Mission) are further augmenting ICU capacities at district-level hospitals, regions that were historically underserved in critical care infrastructure.
The government's Production-Linked Incentive (PLI) scheme for medical devices is simultaneously encouraging domestic ventilator manufacturing, reducing import dependence, and lowering equipment costs for smaller hospitals and clinics. Post-COVID reforms mandating minimum ICU bed-to-ventilator ratios at empaneled hospitals have also institutionalized ventilator procurement as a compliance necessity. Together, these policy levers are ensuring consistent government-driven demand across the public healthcare ecosystem.
Post-COVID Pandemic Preparedness
The COVID-19 pandemic fundamentally and permanently altered India's institutional approach to critical care readiness, generating a durable structural demand boost for ventilators. During the devastating second wave of 2021, the acute shortage of ventilators exposed deep vulnerabilities in India's ICU infrastructure, compelling governments, hospital chains, and healthcare policymakers to undertake comprehensive critical care upgrades. The experience prompted thousands of hospitals from large private chains to district government facilities to invest aggressively in bolstering their ICU infrastructure with advanced ventilatory support systems.
Several state governments established dedicated medical equipment reserves, including ventilator stockpiles, as part of pandemic preparedness policies. Private hospital groups such as Apollo, Fortis, Max Healthcare, and Narayana Health significantly scaled up their ICU bed counts — each bed requiring dedicated ventilator access. Additionally, the pandemic fast-tracked domestic manufacturing capability, with Indian startups like AgVa Healthcare gaining national recognition for producing low-cost, high-quality ventilators. The regulatory environment also streamlined approvals for new ventilator models. This sustained institutional memory of ventilator scarcity continues to drive procurement and replacement cycles across the healthcare system.
Make in India & Domestic Manufacturing Growth
The Make in India initiative is serving as a catalytic force for the ventilator market by enabling affordable, locally manufactured ventilators to penetrate healthcare tiers that were previously inaccessible to high-cost imported equipment. Prior to 2020, India was heavily dependent on imports from global leaders such as Philips, Dräger, and GE Healthcare, which inflated costs and restricted availability for smaller healthcare facilities. The COVID-19 crisis accelerated India's domestic manufacturing capabilities exponentially, with homegrown companies like AgVa Healthcare, Skanray Technologies, BPL Medical Technologies, and Trivitron Healthcare scaling up production rapidly under government contracts.
Government subsidies, PLI scheme incentives, and procurement preferences for domestically manufactured medical devices have further strengthened the financial viability of local ventilator production. Reduced production costs allow domestic manufacturers to offer competitively priced solutions, broadening market access to government district hospitals, rural healthcare centers, and nursing homes operating under constrained budgets. This democratization of ventilator access is unlocking a massive latent demand base in semi-urban and rural India. Ongoing R&D investments by domestic players are also beginning to close the technological gap with international counterparts, further legitimizing Indian-made ventilators in both domestic and export markets.
Technological Advancements & Non-Invasive Ventilation
Rapid innovation in ventilator technology is both expanding the addressable market and stimulating replacement demand for older equipment across India's healthcare facilities. The emergence of portable, smart ventilators equipped with advanced monitoring capabilities, real-time telemetry, Wi-Fi connectivity, and AI-assisted patient management is transforming clinical workflows, particularly in emergency transport and step-down care settings. Critically, the growing shift toward non-invasive ventilation (NIV) is widening the market beyond traditional ICU boundaries. NIV methods, including CPAP and BiPAP, are gaining significant clinical adoption due to their lower infection risk, improved patient comfort, and applicability in general wards and home care environments compared to invasive mechanical ventilation.
This shift toward patient-centric respiratory care is creating entirely new demand segments in the home healthcare and long-term care space. Transport ventilators designed for ambulance networks and mobile ICUs are also gaining traction as India's emergency medical services infrastructure modernizes. Manufacturers are integrating multi-mode ventilation algorithms and automated weaning protocols to improve outcomes, making newer devices clinically compelling compared to legacy equipment. These technological shifts are accelerating both fresh procurement and fleet modernization cycles across Indian hospitals.
Download Free Sample Report
Key Market Challenges
Growing Incidences of Ventilator-associated
Pneumonia
Ventilator-associated pneumonia is a major concern in Indian critical care and is increasingly shaping how hospitals use and upgrade ventilator support, because recent Indian evidence reported VAP incidence of 39.43 per 1,000 ventilator days in a neurocritical care setting and found that 24.94 percent of ventilated patients developed the infection, reinforcing the need for safer ventilation practices and closer ICU surveillance. This risk is pushing hospitals to tighten hand hygiene, early weaning, head elevation, chlorhexidine mouth care, and related infection-control steps, with an Indian survey showing 96.8 percent of intensivists used VAP bundles and 97.6 percent followed hand-washing protocols.
For instance, India’s ventilator capacity was strengthened when PM CARES funded 50,000 Made-in-India ventilators, including 30,000 from Bharat Electronics and 10,000 from AgVa Healthcare, giving hospitals a larger installed base to deploy invasive or non-invasive respiratory support more selectively as they try to reduce prolonged ventilation exposure and associated infection risk. At the same time, companies are responding with more adaptable systems, as Getinge said its Servo-c platform builds on more than 50 years of Servo performance and avoids proprietary disposables to improve uptime and cost efficiency, supporting a broader shift toward safer and more flexible respiratory care pathways in India.
Highly Expensive Materials in the Manufacture of
Ventilators
The high cost of materials used in ventilator manufacturing remains a major barrier in India because a share of the medical-device supply chain still depends on imports, which raises landed costs and increases procurement pressure for hospitals, especially beyond urban centers. Government data shows India imported medical devices worth USD 7,492 million in 2022-23 while exports stood at USD 3,391 million, highlighting the foreign-exchange exposure that can push up input costs across critical-care equipment categories relevant to ventilators.
To ease that burden, the Production Linked Incentive scheme for medical devices has an outlay of Rs 3,420 crore and 26 approved applicants, including the anaesthetics and cardio-respiratory segment tied to ventilator ecosystems. The Medical Devices Parks scheme adds Rs 400 crore, with Rs 100 crore each approved for Himachal Pradesh, Madhya Pradesh, Tamil Nadu, and Uttar Pradesh to build infrastructure. For instance, Getinge said its Servo-c ventilator platform draws on more than 50 years of Servo performance and avoids proprietary consumables, showing how design efficiency can help hospitals manage costs effectively.
Key Market Trends
Alarming Rise in Air Pollution
The Government of India has been actively investing in the healthcare sector to enhance national infrastructure, with a particular focus on procuring state-of-the-art medical equipment, including ventilators. Recognizing the critical role these devices play in saving lives, the government has made significant strides to ensure their adequate supply. Under the Production-Linked Incentive Scheme for medical devices, the government allocated a total financial outlay of ₹3,420 crore for the period 2020–21 to 2027–28, enabling domestic manufacturers to scale ventilator production.
The demand for ventilators has surged significantly, driven by the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease and asthma, further accelerated by the global pandemic. For instance, the government placed orders for 30,000 ventilators with Bharat Electronics Limited in collaboration with Skanray Technologies, and an additional 10,000 units with AgVa Healthcare. The government's investments extend strategically beyond urban centers to rural and semi-urban regions, aiming to bridge healthcare gaps and build a resilient, universally accessible healthcare ecosystem.
Increasing Government Initiatives
The Indian market is currently experiencing a
significant surge in ventilator demand, driven by several factors. One of the primary drivers of this increase is the government's proactive efforts to enhance the country's health
infrastructure. In response to the global pandemic, the government has been
actively procuring a substantial number of ventilators, ensuring the healthcare system is well-equipped to handle any potential
crisis.
This bolstering of the health infrastructure goes
beyond being a mere short-term response. It serves as a strategic move towards
long-term preparedness for future health emergencies. By
investing in and expanding the availability of ventilators, the government is
not only addressing the immediate needs but also laying the foundation for a
resilient healthcare system capable of handling unforeseen challenges.
The government's initiatives to promote local manufacturing and subsidize domestic companies
have played a pivotal role in boosting the ventilator market in India. These
measures not only support the domestic economy but also ensure the availability
of high-quality ventilators manufactured domestically. The combination of
increased government initiatives, strategic planning for long-term
preparedness, and support for local manufacturing has contributed to the
significant growth of the ventilator market in India. This trend reflects a commitment
to ensuring the well-being of the population and to effectively responding to healthcare challenges in the present and the future.
Segmental Insights
Equipment Type Insights
In the highly competitive medical device market, the non-invasive ventilation
segment stands out as the dominant force. Non-invasive ventilators, which provide breathing support via options such as face masks, nasal masks, or helmets, have become the preferred choice for both patients and
healthcare professionals. This preference can be attributed to numerous benefits, including reduced infection risk and greater comfort compared to
invasive ventilators.
However, the increasing
prevalence of respiratory diseases, such as chronic obstructive pulmonary
disease (COPD) and sleep apnea, has fueled the demand for non-invasive
ventilators. The convenience and ease of use of these devices have made them particularly popular in the rapidly growing home healthcare market.
Patients now have the opportunity to receive high-quality respiratory support
in the comfort of their own homes. What sets non-invasive ventilators apart is
their advanced technology and user-friendly features. These devices are
revolutionizing the delivery of respiratory care, greatly improving patients' quality of life worldwide. With continuous advancements in the
field, non-invasive ventilators are paving the way for a brighter future in
respiratory care, ensuring that patients receive the best possible treatment
and support.
End User Insights
Based on end user, the hospitals and clinics segment is emerging as the fastest-growing end-user category in India’s ventilator market. This growth is fueled by their robust infrastructure, ability to integrate advanced medical technologies, and the availability of highly skilled healthcare professionals. These institutions are increasingly investing in state-of-the-art ventilators to enhance patient outcomes and expand their critical care capabilities. The surge in patient inflow, particularly those requiring intensive respiratory support, further accelerates demand within hospitals and clinics.
They serve as centralized hubs for managing critical cases, including respiratory illnesses, post-surgical recovery, and emergency interventions, which positions them as primary adopters of technologically advanced ventilators. Moreover, hospitals and clinics are at the forefront of driving innovation in respiratory care, ensuring that patients benefit from cutting-edge equipment and specialized treatment. Their growing commitment to upgrading facilities and expanding intensive care units underscores their role as the fastest-growing segment in India’s ventilator market, shaping the future of advanced healthcare delivery in the country.
Download Free Sample Report
Regional Insights
South India currently dominated the India
ventilator market. This is ascribed due to its advanced healthcare infrastructure and high
adoption rate of ventilator systems. However, North India is expected to experience remarkable growth during the forecast period. This is attributed to the
proactive measures taken by several North Indian states, such as Uttar Pradesh,
Delhi, and Bihar, in boosting healthcare expenditures. These states are
actively investing in strengthening their healthcare infrastructure to better respond to public health emergencies, including the ongoing COVID-19
pandemic. The increased focus on healthcare infrastructure development is
expected to create lucrative opportunities for the ventilator market in North
India.
The rising awareness of the importance of respiratory care and the growing prevalence of respiratory disorders in the region are driving market growth. The growing geriatric population, coupled with high pollution levels in some North Indian cities, further increases the demand for ventilators in this region. With
the concerted efforts to enhance healthcare infrastructure and the rising
demand for advanced respiratory care solutions, the India ventilator market is
poised for significant growth in both South and North India during the forecast
period.
Recent Developments
- In September 2025, the Yamuna Expressway Industrial Development Authority issued a letter of intent to a premier Indian medical systems and devices firm, allocating a three-acre plot at the YEIDA MedTech Park in Greater Noida for a Rs 60-crore ventilator manufacturing project. The company, which already supplied ventilators across India as well as to Nepal, Bangladesh, and Sri Lanka, said the expanded facility would also support new product categories such as X-ray machines, CT scanners, and oncology infusion devices, pointing toward a broader domestic medtech manufacturing buildout. This development was important because it anchored specialized ventilator production within a dedicated medtech manufacturing zone, supporting the government's objective of reducing import dependency in critical medical equipment.
- In May 2025, India's Union Minister of Science and Technology Dr. Jitendra Singh formally launched an upgraded version of the Noccarc V730i ICU ventilator, equipped with expanded neonatal modes and advanced critical care functionalities at a National Technology Day event. Noccarc said the V730i now covers the full spectrum of ventilation from adult and paediatric to neonatal patients, with tidal volumes starting from 15 mL, and integrates cloud-based remote monitoring through the HorizonView platform via GSM, Wi-Fi, and LAN connectivity. This launch was significant because it turned an indigenously designed IIT Kanpur-incubated ventilator into a universal critical-care device replacing more expensive imported alternatives.
- In March 2025, BPL Medical Technologies showcased its Löwenstein-branded elisa 300 and elisa 600 ICU ventilators at CRITICARE 2025, the 31st Annual National Conference of the Indian Society of Critical Care Medicine, held in Kochi. The conference provided a platform for clinicians and technical specialists to review the ventilators' performance capabilities in high-acuity settings, with BPL using the event to demonstrate the company's expanding critical care portfolio that also included new patient monitors and ICU management tools. The development mattered because it marked BPL Medical's push to position Indian-branded but globally co-developed ventilator platforms more prominently within the specialist critical-care community, which has traditionally relied heavily on imported equipment.
Key Market Players
|
By Equipment
Type
|
By Product
Type
|
By Mode
|
By Source
|
By End User
|
By Region
|
- Invasive
Ventilation
- Non-Invasive
Ventilation
|
- Adult/Pediatric
- Neonatal/Infants
|
- Combined
Mode
- Volume Mode
- Pressure
Mode
- Others
|
|
- Hospitals
& Clinics
- Emergency
Medical Services
- Others
|
- North India
- South India
- West India
- East India
|
Report Scope:
In this report, the India Ventilator Market has
been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- India Ventilator Market, By Equipment Type:
o Invasive Ventilation
o Non-Invasive Ventilation
- India Ventilator Market, By Product Type:
o Adult/Pediatric
o Neonatal/Infants
- India Ventilator Market, By Mobility:
o Standalone
o Portable
- India Ventilator Market, By Mode:
o Combined Mode
o Volume Mode
o Pressure Mode
o Others
- India Ventilator Market, By Source:
o Domestic
o Import
- India Ventilator Market, By End User:
o Hospitals & Clinics
o Emergency Medical Services
o Others
- India Ventilator Market, By Region:
o North
o South
o West
o East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the India Ventilator
Market.
Available Customizations:
India Ventilator Market report with the
given market data, TechSci Research offers customizations according to a
company's specific needs. The following customization options are available for
the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
India Ventilator Market is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]